Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Jan;16(1):103-12.
doi: 10.1093/neuonc/not145. Epub 2013 Dec 4.

Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis

Jiaxin Zhao  1 , Wenjie Ma, Hong Zhao
Affiliations
Meta-Analysis

Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis

Jiaxin Zhao et al. Neuro Oncol. 2014 Jan.

Abstract

Background: Glioma is rarely curable, and factors that influence the prognosis of glioma patients are not fully understood. Loss of heterozygosity (LOH) of 1p/19q has long been known to be a typical molecular signature of oligodendroglial neoplasms. However, whether LOH of 1p/19q is associated with survival in gliomas remains controversial. Here our goal was to evaluate the association between LOH of 1p/19q and progression-free survival (PFS) and overall survival (OS) by conducting a meta-analysis among glioma cases.

Methods: The PubMed and Embase databases were searched from the earliest records to May 2013 to identify studies that met prestated inclusion criteria. Reference lists of retrieved articles were also reviewed. Three authors independently extracted information needed for further analysis. Either a fixed- or a random-effects model was used to calculate the overall combined hazard ratio (HR) estimates.

Results: Twenty-eight eligible studies involving 3 408 cases were included in the meta-analysis. Compared with the chromosomal intact group, codeletion of 1p and 19q was associated with a better PFS (HR = 0.63; 95% CI, 0.52-0.76) and OS (HR = 0.43; 95% CI, 0.35-0.53). Subgroup analyses showed this association to be independent of detection methods and the grades and subtypes of gliomas. Furthermore, isodeletion of chromosome 1p predicted a similar favorable disease outcome (PFS: HR = 0.68; 95% CI, 0.47-0.97) (OS: HR = 0.51; 95% CI, 0.35-0.75), especially in low-grade gliomas, whereas isodeletion of 19q only indicated longer PFS (HR = 0.70; 95% CI, 0.56-0.87).

Conclusion: Codeletion of 1p and 19q is associated with better survival rates in glioma. Isodeletion of 1p predicts similar outcomes but to a lesser extent, whereas the effects of isodeletion of 19q remained only marginal.

Keywords: 19q; 1p; glioma; meta-analysis; survival.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Flow chart of study selection. Flow chart shows literature search for studies of loss of 1p/19q heterozygosity in relation to survivals in glioma.
Fig. 2.
Fig. 2.
Forest plots showing hazard ratios of codeletion of 1p/19q for progression-free survival (a) and overall survival (b). Each study is shown by the point estimate of the hazard ratio and 95% confidence intervals (extending lines). The diamonds represent the estimated pooled effect (labeled total).
Fig. 3.
Fig. 3.
Forest plots showing hazard ratios of isodeletion of 1p for progression-free survival (a) and overall survival (b).
Fig. 4.
Fig. 4.
Forest plots showing hazard ratios of isodeletion of 19q for progression-free survival (a) and overall survival (b).
See this image and copyright information in PMC

References

    1. Goodenberger ML, Jenkins RB. Genetics of adult glioma. Cancer Genet. 2012;205(12):613–621. - PubMed
    1. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109. - PMC - PubMed
    1. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061–1068. - PMC - PubMed
    1. Jenkins RB, Blair H, Ballman KV, et al. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res. 2006;66(20):9852–9861. - PubMed
    1. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol. 1994;145(5):1175–1190. - PMC - PubMed

Publication types